Inductive tissue engineering with protein and DNA-releasing scaffolds.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular Biosystems

• Publication date

  2006-12-12

• Fields of study

  Biology, Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1039/B514174PPMID 16880921PMCID PMC2657198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation.

  2006cited by this paper
• The non‐proteolytically active thrombin peptide TP508 stimulates angiogenic sprouting

  2006cited by this paper
• Design of modular non-viral gene therapy vectors.

  2006cited by this paper
• Mediation of Biomaterial–Cell Interactions by Adsorbed Proteins: A Review

  2005cited by this paper
• DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach.

  2005cited by this paper
• Fabrication of a cell array on ultrathin hydrophilic polymer gels utilising electron beam irradiation and UV excimer laser ablation.

  2005cited by this paper
• Stem cell‐based composite tissue constructs for regenerative medicine

  2005cited by this paper
• A cultural renaissance: in vitro cell biology embraces three-dimensional context.

  2005cited by this paper
• The mechanism of naked DNA uptake and expression.

  2005cited by this paper
• Lentiviral Transfection with the PDGF-B Gene Improves Diabetic Wound Healing

  2005cited by this paper
• Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

  2005cited by this paper
• Porous scaffold design for tissue engineering

  2005cited by this paper
• Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?

  2005cited by this paper
• Repeated injuries dramatically affect cells of the oligodendrocyte lineage: Effects of PDGF and NT‐3 in vitro

  2005cited by this paper
• In vitro Characterization of TGF-β1 Release from Genetically Modified Fibroblasts in Ca2+-Alginate Microcapsules

  2005cited by this paper
• Embryonic stem cell differentiation: emergence of a new era in biology and medicine.

  2005influential reference
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

  2005cited by this paper
• Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

  2005cited by this paper
• PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

  2005cited by this paper
• Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern.

  2005cited by this paper
• Gene delivery through cell culture substrate adsorbed DNA complexes.

  2005cited by this paper
• Long-Term In Vivo Gene Expression via Delivery of PEI–DNA Condensates from Porous Polymer Scaffolds

  2005cited by this paper
• Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.

  2005cited by this paper
• Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.

  2005cited by this paper
• Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

  2005cited by this paper
• Generating controlled molecular gradients in 3D gels.

  2005cited by this paper
• Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

  2005cited by this paper
• Neurotrophin releasing single and multiple lumen nerve conduits.

  2005cited by this paper
• Matrigel: basement membrane matrix with biological activity.

  2005cited by this paper
• Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.

  2005cited by this paper
• Combined chondrocyte-copolymer implantation with slow release of basic fibroblast growth factor for tissue engineering an auricular cartilage construct.

  2005cited by this paper
• Thrombin peptide (TP508) promotes fracture repair by up‐regulating inflammatory mediators, early growth factors, and increasing angiogenesis

  2005cited by this paper
• Design and development of polymers for gene delivery

  2005cited by this paper
• [Preparation of controlled release microsphere incorporating bFGF and its effect on Schwann cells].

  2005cited by this paper
• Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration.

  2005cited by this paper
• Encapsulation of carbon nanotubes by self-assembling peptide amphiphiles.

  2005cited by this paper
• Patterning poly(organophosphazenes) for selective cell adhesion applications.

  2005cited by this paper
• Embryonic stem cells: prospects for developmental biology and cell therapy.

  2005influential reference
• Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.

  2005cited by this paper
• Non-viral gene delivery for local and controlled DNA release.

  2005cited by this paper
• Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.

  2005cited by this paper
• Preparation and Biological Characteristics of Recombinant Human Bone Morphogenetic Protein-2-Loaded Dextran-co-Gelatin Hydrogel Microspheres, in vitro and in vivo Studies

  2005cited by this paper
• Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4)

  2005cited by this paper
• Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds.

  2005cited by this paper
• Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2.

  2005cited by this paper
• Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering

  2005cited by this paper
• Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits.

  2005cited by this paper
• Poly(lactide-co-glycolide) microspheres as a moldable scaffold for cartilage tissue engineering.

  2005cited by this paper
• Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.

  2004cited by this paper
• Microspheres for controlled release drug delivery

  2004cited by this paper
• Integrin Interactions with Immobilized Peptides in Polyethylene Glycol Diacrylate Hydrogels

  2004cited by this paper
• Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface.

  2004cited by this paper
• Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

  2004cited by this paper
• Signaling, internalization, and intracellular activity of fibroblast growth factor.

  2004cited by this paper
• Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways.

  2004cited by this paper
• Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity.

  2004cited by this paper
• Immobilized concentration gradients of nerve growth factor guide neurite outgrowth.

  2004cited by this paper
• Incorporation of polymer microspheres within fibrin scaffolds for the controlled delivery of FGF-1

  2004cited by this paper
• Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold.

  2004cited by this paper
• Tissue engineering: the end of the beginning.

  2004cited by this paper
• MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing.

  2004cited by this paper
• Cellular alignment by grafted adhesion peptide surface density gradients.

  2004cited by this paper
• Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.

  2004cited by this paper
• Long-Term Outcome of Growth Hormone Therapy in Children and Adolescents

  2004cited by this paper
• Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells.

  2004cited by this paper
• Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration

  2004cited by this paper
• Polymeric Scaffolds for Bone Tissue Engineering

  2004cited by this paper
• Gene delivery from polymer scaffolds for tissue engineering

  2004cited by this paper
• Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.

  2004cited by this paper
• Controlled release systems for DNA delivery.

  2004cited by this paper
• Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.

  2004cited by this paper
• Designing materials for biology and medicine

  2004cited by this paper
• Biomaterial–microvasculature interaction on polymers after implantation in mice

  2004cited by this paper
• Injectable cartilage tissue engineering

  2004cited by this paper
• Collagenous matrices as release carriers of exogenous growth factors.

  2004cited by this paper
• To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF

  2004cited by this paper
• Synergistic Effects of Brain-Derived Neurotrophic Factor and Chondroitinase ABC on Retinal Fiber Sprouting after Denervation of the Superior Colliculus in Adult Rats

  2003cited by this paper
• Controllable delivery of non-viral DNA from porous scaffolds.

  2003cited by this paper
• Modeling tissue-specific signaling and organ function in three dimensions

  2003cited by this paper
• Genomic analysis of smooth muscle cells in three‐dimensional collagen matrix

  2003cited by this paper
• Biopolymeric delivery matrices for angiogenic growth factors.

  2003cited by this paper
• Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF‐inhibitor to the rabbit tibia during distraction osteogenesis

  2003cited by this paper
• RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

  2003cited by this paper
• Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics

  2003cited by this paper
• Evidence in support of signaling endosome-based retrograde survival of sympathetic neurons.

  2003cited by this paper
• Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

  2003cited by this paper
• Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage.

  2003cited by this paper
• Ligand-Induced Internalization of the p75 Neurotrophin Receptor: A Slow Route to the Signaling Endosome

  2003cited by this paper
• Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel.

  2003cited by this paper
• Controlled release of nerve growth factor enhances sciatic nerve regeneration.

  2003cited by this paper
• Protein-based signaling systems in tissue engineering.

  2003cited by this paper
• Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth

  2003cited by this paper
• Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.

  2003cited by this paper
• Development of a porous poly(L-lactic acid)/hydroxyapatite/collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defect.

  2003cited by this paper
• Gene therapy with viral vectors.

  2003cited by this paper
• Precursor Tissue Analogs as a Tissue-Engineering Strategy

  2003cited by this paper
• Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury.

  2003cited by this paper
• Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro.

  2003cited by this paper
• Fabrication of novel biomaterials through molecular self-assembly

  2003cited by this paper
• Materials as morphogenetic guides in tissue engineering.

  2003cited by this paper

• Structural DNA nanotechnology at the nexus of next-generation bio-applications: challenges and perspectives

  2023cites this paper
• Scaffolds with drug delivery capability

  2022cites this paper
• Nerve tissue engineering on degradable scaffold

  2022cites this paper
• The biological applications of DNA nanomaterials: current challenges and future directions

  2021cites this paper
• Microbial exopolysaccharide-based nano-carriers with unique multi-functionalities for biomedical sectors

  2020cites this paper
• Biocompatibility of materials and its relevance to drug delivery and tissue engineering

  2020cites this paper
• Localised non-viral delivery of nucleic acids for nerve regeneration in injured nervous systems.

  2019cites this paper
• Poloxamine/fibrin hybrid hydrogels for non‐viral gene delivery

  2017cites this paper
• Biopolymer-based functional composites for medical applications

  2017cites this paper
• Polymer nanocomposites for drug delivery applications in bone tissue regeneration

  2016cites this paper
• 7 – Nanotechnology-controlled drug delivery for treating bone diseases

  2015cites this paper
• Gene Delivery Strategies to Promote Spinal Cord Repair

  2015cites this paper
• Bridging the lesion—engineering a permissive substrate for nerve regeneration

  2015cites this paper
• Neural Stem Cells and Induced Neurons for Nerve Injury Repair

  2015cites this paper
• Bone substitutes in orthopaedic surgery: from basic science to clinical practice

  2014cites this paper
• Bioactivated Materials for Cell and Tissue Guidance

  2014cites this paper
• Spatiotemporal Genetic Control of Cellular Systems

  2014cites this paper
• PEGylated poly(ethylene imine) as a copolymer for gene delivery from hyaluronic acid hydrogels

  2014cites this paper
• IGF2: an endocrine hormone to improve islet transplant survival.

  2014cites this paper
• Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering

  2013cites this paper
• Bone Enhancement with BMP-2 for Safe Clinical Translation

  2013cites this paper
• Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy – The Turning Point of Cell-Based Regenerative Medicine

  2013cites this paper
• RNAi functionalized collagen-chitosan/silicone membrane bilayer dermal equivalent for full-thickness skin regeneration with inhibited scarring.

  2013cites this paper
• Controlled Release Strategies for Bone, Cartilage, and Osteochondral Engineering—Part I: Recapitulation of Native Tissue Healing and Variables for the Design of Delivery Systems

  2013influential citation
• A peptidic hydrogel that may behave as a “Trojan Horse”

  2013cites this paper
• Emerging Technologies for Assembly of Microscale Hydrogels

  2012cites this paper
• From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.

  2012cites this paper
• DNA complexes with Ni nanoparticles: structural and functional properties

  2012cites this paper
• Chitosan–chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine

  2012cites this paper
• Fluorescence monitoring of trypsin adsorption in layer-by-layer membrane systems.

  2012cites this paper
• Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release.

  2012cites this paper
• Scaffold: a novel carrier for cell and drug delivery.

  2012cites this paper
• Bioengineering methods for analysis of cells in vitro.

  2012cites this paper
• Three-dimensional scaffold containing EGF incorporated biodegradable polymeric nanoparticles for stem cell based tissue engineering applications

  2011cites this paper
• Advanced cell therapies with and without scaffolds

  2011cites this paper
• Imidazole-grafted chitosan-mediated gene delivery: in vitro study on transfection, intracellular trafficking and degradation.

  2011cites this paper
• Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds.

  2011cites this paper
• Biomimeticity in tissue engineering scaffolds through synthetic peptide modifications-altering chemistry for enhanced biological response.

  2011cites this paper
• Viscoelastic behavior, deformation, and rupture of cells.

  2011cites this paper
• Hybrid 3D structure of poly(d,l-lactic acid) loaded with chitosan/chondroitin sulfate nanoparticles to be used as carriers for biomacromolecules in tissue engineering

  2010cites this paper
• Non-viral polyplexes: Scaffold mediated delivery for gene therapy

  2010cites this paper
• Polyelectrolyte Complexes as Smart Nanoengineered Systems for Biotechnology and Gene Delivery

  2010cites this paper
• Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.

  2010cites this paper
• Engineering hydrogels as extracellular matrix mimics.

  2010cites this paper
• Synthesis and manufacture of photocrosslinkable poly(caprolactone)-based 3D scaffolds for tissue engineering applications

  2010cites this paper
• Efficient transfer of reporter gene-loaded nanoparticles to bone marrow stromal cells (D1) by reverse transfection.

  2010cites this paper
• Hydrogel compositions for nonviral gene delivery

  2009cites this paper
• Polysaccharide/polyaminoacid composite scaffolds for modified DNA release.

  2009cites this paper
• Bone tissue engineering: A review in bone biomimetics and drug delivery strategies

  2009cites this paper
• Nanotechnology controlled drug delivery for treating bone diseases

  2009cites this paper
• In vitro Tissue Engineering of Liver and Primary Lymphoid Tissues with Inverted Colloidal Crystal Scaffolds for Drug Testing Application.

  2009cites this paper
• Tetrapeptide-based hydrogels: for encapsulation and slow release of an anticancer drug at physiological pH.

  2009cites this paper
• Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel.

  2009cites this paper
• Imidazole-grafted chitosan-mediated gene delivery : in vitro study on transfection , intracellular trafficking and degradation

  2009cites this paper
• Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration

  2009cites this paper
• Nanoscale Mechanisms for Assembly of Biomaterials

  2009cites this paper
• Gene delivery systems for gene therapy in tissue engineering and central nervous system applications.

  2008cites this paper
• Bioinspired tissue engineering: the great promise of protein delivery technologies.

  2008cites this paper
• Three-Dimensional Cell Culture Matrices: State of the Art

  2008cites this paper
• Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration.

  2008cites this paper
• Synthetic sustained gene delivery systems.

  2008cites this paper
• Controlled drug delivery in tissue engineering.

  2008cites this paper
• Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration

  2008cites this paper
• Gene delivery systems for gene therapy in tissue engineering and central nervous system applications

  2008cites this paper
• Cartilage tissue engineering: controlled release of growth factors. Effects of GDF-5, sexual steroid hormons and oxygen

  2007cites this paper
• Combining tissue engineering and drug deliveryTissue Engineering Using Ceramics and Polymers

  2007cites this paper
• Tissue Engineering Using Ceramics and Polymers

  2007cites this paper
• Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism

  2007cites this paper
• Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis.

  2007cites this paper
• Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.

  2007cites this paper
• Non-viral vector delivery from PEG-hyaluronic acid hydrogels.

  2007cites this paper
• Matrices and scaffolds for DNA delivery in tissue engineering.

  2007cites this paper
• Gene Technology in Tissue Engineering

  2006cites this paper
• Novel techniques of fabricating porous, biodegradable polymer scaffolds for sustained drug release

  2006influential citation
• Long-Term In Vivo Gene Expression via Delivery of PEI–DNA Condensates from Porous Polymer Scaffolds

  2005cites this paper